Report Detail

Other Global Mucormycosis Market Size, Status and Forecast 2019-2025

  • RnM2800147
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Mucormycosis Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Rhizopus
      • 1.4.3 Rhizomucor
      • 1.4.4 Cunninghamella
      • 1.4.5 Apophysomyces
      • 1.4.6 Saksenaea
      • 1.4.7 Lichtheimia (Absidia)
      • 1.4.8 Mucor
    • 1.5 Market by Application
      • 1.5.1 Global Mucormycosis Market Share by Application (2014-2025)
      • 1.5.2 Hospitals & Clinics
      • 1.5.3 Medical Institutes
      • 1.5.4 Research Organization
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Mucormycosis Market Size
    • 2.2 Mucormycosis Growth Trends by Regions
      • 2.2.1 Mucormycosis Market Size by Regions (2014-2025)
      • 2.2.2 Mucormycosis Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Mucormycosis Market Size by Manufacturers
      • 3.1.1 Global Mucormycosis Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Mucormycosis Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Mucormycosis Market Concentration Ratio (CR5 and HHI)
    • 3.2 Mucormycosis Key Players Head office and Area Served
    • 3.3 Key Players Mucormycosis Product/Solution/Service
    • 3.4 Date of Enter into Mucormycosis Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Mucormycosis Market Size by Type (2014-2019)
    • 4.2 Global Mucormycosis Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Mucormycosis Market Size (2014-2019)
    • 5.2 Mucormycosis Key Players in United States
    • 5.3 United States Mucormycosis Market Size by Type
    • 5.4 United States Mucormycosis Market Size by Application

    6 Europe

    • 6.1 Europe Mucormycosis Market Size (2014-2019)
    • 6.2 Mucormycosis Key Players in Europe
    • 6.3 Europe Mucormycosis Market Size by Type
    • 6.4 Europe Mucormycosis Market Size by Application

    7 China

    • 7.1 China Mucormycosis Market Size (2014-2019)
    • 7.2 Mucormycosis Key Players in China
    • 7.3 China Mucormycosis Market Size by Type
    • 7.4 China Mucormycosis Market Size by Application

    8 Japan

    • 8.1 Japan Mucormycosis Market Size (2014-2019)
    • 8.2 Mucormycosis Key Players in Japan
    • 8.3 Japan Mucormycosis Market Size by Type
    • 8.4 Japan Mucormycosis Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Mucormycosis Market Size (2014-2019)
    • 9.2 Mucormycosis Key Players in Southeast Asia
    • 9.3 Southeast Asia Mucormycosis Market Size by Type
    • 9.4 Southeast Asia Mucormycosis Market Size by Application

    10 India

    • 10.1 India Mucormycosis Market Size (2014-2019)
    • 10.2 Mucormycosis Key Players in India
    • 10.3 India Mucormycosis Market Size by Type
    • 10.4 India Mucormycosis Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Mucormycosis Market Size (2014-2019)
    • 11.2 Mucormycosis Key Players in Central & South America
    • 11.3 Central & South America Mucormycosis Market Size by Type
    • 11.4 Central & South America Mucormycosis Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott Laboratories
      • 12.1.1 Abbott Laboratories Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Mucormycosis Introduction
      • 12.1.4 Abbott Laboratories Revenue in Mucormycosis Business (2014-2019)
      • 12.1.5 Abbott Laboratories Recent Development
    • 12.2 Biocon
      • 12.2.1 Biocon Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Mucormycosis Introduction
      • 12.2.4 Biocon Revenue in Mucormycosis Business (2014-2019)
      • 12.2.5 Biocon Recent Development
    • 12.3 Cadila Pharmaceuticals
      • 12.3.1 Cadila Pharmaceuticals Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Mucormycosis Introduction
      • 12.3.4 Cadila Pharmaceuticals Revenue in Mucormycosis Business (2014-2019)
      • 12.3.5 Cadila Pharmaceuticals Recent Development
    • 12.4 Novartis
      • 12.4.1 Novartis Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Mucormycosis Introduction
      • 12.4.4 Novartis Revenue in Mucormycosis Business (2014-2019)
      • 12.4.5 Novartis Recent Development
    • 12.5 Merck
      • 12.5.1 Merck Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Mucormycosis Introduction
      • 12.5.4 Merck Revenue in Mucormycosis Business (2014-2019)
      • 12.5.5 Merck Recent Development
    • 12.6 Roche
      • 12.6.1 Roche Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Mucormycosis Introduction
      • 12.6.4 Roche Revenue in Mucormycosis Business (2014-2019)
      • 12.6.5 Roche Recent Development
    • 12.7 Bristol Myers Squibb
      • 12.7.1 Bristol Myers Squibb Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Mucormycosis Introduction
      • 12.7.4 Bristol Myers Squibb Revenue in Mucormycosis Business (2014-2019)
      • 12.7.5 Bristol Myers Squibb Recent Development
    • 12.8 Pfizer
      • 12.8.1 Pfizer Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Mucormycosis Introduction
      • 12.8.4 Pfizer Revenue in Mucormycosis Business (2014-2019)
      • 12.8.5 Pfizer Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Mucormycosis is any fungal infection caused by fungi in the order Mucorales. Generally, species in the Mucor, Rhizopus, Absidia, and Cunninghamella genera are most often implicated. The disease is often characterized by hyphae growing in and around blood vessels and can be potentially life-threatening in diabetic or severely immunocompromised individuals.
      If mucormycosis is suspected, amphotericin B therapy should be immediately administered due to the rapid spread and high mortality rate of the disease. Amphotericin B is usually administered for an additional 4–6 weeks after initial therapy begins to ensure eradication of the infection. After administration of either amphotericin B or posaconazole, surgical removal of the "fungus ball" is indicated. The disease must be monitored carefully for any signs of reemergence.
      In 2018, the global Mucormycosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Mucormycosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mucormycosis development in United States, Europe and China.

      The key players covered in this study
      Abbott Laboratories
      Biocon
      Cadila Pharmaceuticals
      Novartis
      Merck
      Roche
      Bristol Myers Squibb
      Pfizer

      Market segment by Type, the product can be split into
      Rhizopus
      Rhizomucor
      Cunninghamella
      Apophysomyces
      Saksenaea
      Lichtheimia (Absidia)
      Mucor

      Market segment by Application, split into
      Hospitals & Clinics
      Medical Institutes
      Research Organization

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Mucormycosis status, future forecast, growth opportunity, key market and key players.
      To present the Mucormycosis development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Mucormycosis are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Mucormycosis . Industry analysis & Market Report on Mucormycosis is a syndicated market report, published as Global Mucormycosis Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Mucormycosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,026.36
      4,539.54
      6,052.71
      3,501.44
      5,252.17
      7,002.89
      423,309.90
      634,964.85
      846,619.80
      277,407.78
      416,111.67
      554,815.56
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report